We are live on
!
Find out more
Nuveen Portfolio holdings
AUM
$419B
1-Year Est. Return
43.02%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+43.02%
3 Year Est. Return
+139.43%
5 Year Est. Return
+185.66%
10 Year Est. Return
+615.13%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.54B
Cap. Flow
% of AUM
-0.62%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.84% |
| 2 | Healthcare | 15.13% |
| 3 | Financials | 12.34% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Regeneron Pharmaceuticals
REGN
$81.1B
| $264M | 0.11% |
383,947
-5,807
| -1% | -$3.65M |
|
177
Lockheed Martin
LMT
$120B
| $263M | 0.11% |
680,127
-181,269
| -21% | -$75.7M |
|
178
Arista Networks
ANET
$261B
| $262M | 0.11% |
9,288,624
+3,741,936
| +67% | +$108M |
|
179
Truist Financial
TFC
$58.2B
| $261M | 0.11% |
5,983,583
-299,969
| -5% | -$14.4M |
|
180
Extra Space Storage
EXR
$28.2B
| $260M | 0.11% |
1,506,846
-117,264
| -7% | -$22.2M |
|
181
Illinois Tool Works
ITW
$78.1B
| $257M | 0.1% |
1,420,480
-4,788
| -0.3% | -$945K |
|
182
Intercontinental Exchange
ICE
$86.6B
| $256M | 0.1% |
2,837,086
-26,859
| -0.9% | -$2.69M |
|
183
Xcel Energy
XEL
$43.6B
| $256M | 0.1% |
4,002,933
-899,525
| -18% | -$65.5M |
|
184
SLB Ltd
SLB
$76.5B
| $256M | 0.1% |
7,124,337
+1,201,453
| +20% | +$43.6M |
|
185
TE Connectivity
TEL
$63.3B
| $255M | 0.1% |
2,314,317
-65,865
| -3% | -$8.2M |
|
186
Phillips 66
PSX
$102B
| $254M | 0.1% |
3,150,706
+401,127
| +15% | +$34.2M |
|
187
International Flavors & Fragrances
IFF
$21.9B
| $254M | 0.1% |
2,791,747
+122,767
| +5% | +$14.1M |
|
188
3M
MMM
$87.4B
| $252M | 0.1% |
2,730,505
-42,962
| -2% | -$4.71M |
|
189
Stryker
SYK
$104B
| $247M | 0.1% |
1,219,352
-227,019
| -16% | -$47.8M |
|
190
Keurig Dr Pepper
KDP
$43.5B
| $245M | 0.1% |
6,848,609
-293,379
| -4% | -$11.1M |
|
191
LPL Financial
LPLA
$24.8B
| $243M | 0.1% |
1,112,312
-84,923
| -7% | -$18.1M |
|
192
Chipotle Mexican Grill
CMG
$39.6B
| $240M | 0.1% |
7,969,500
-589,300
| -7% | -$18.3M |
|
193
eBay
EBAY
$48B
| $239M | 0.1% |
6,485,386
-575,478
| -8% | -$25.6M |
|
|
TWTR
194
DELISTED
Twitter, Inc.
TWTR
| $237M | 0.1% |
5,398,642
-2,001,273
| -27% | -$81.5M |
|
195
Rexford Industrial Realty
REXR
$8.36B
| $236M | 0.1% |
4,536,443
-478,623
| -10% | -$29.6M |
|
|
VMRK
196
Vivmark Residential
VMRK
$47.6B
| $235M | 0.1% |
3,495,803
-136,818
| -4% | -$10.1M |
|
197
Altria Group
MO
$115B
| $231M | 0.09% |
5,720,555
-133,833
| -2% | -$5.84M |
|
198
Hubbell
HUBB
$24.7B
| $230M | 0.09% |
1,029,262
-134,605
| -12% | -$28.3M |
|
199
Johnson Controls International
JCI
$91B
| $229M | 0.09% |
4,654,680
-37,920
| -0.8% | -$2.01M |
|
200
Freeport-McMoran
FCX
$104B
| $229M | 0.09% |
8,361,704
-445,787
| -5% | -$13M |
|
Similar funds
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.